Angina Market Size, Share, Growth, and Industry Analysis, By Type (Beta Blockers, Calcium Antagonists, Anticoagulants, Antiplatelet, Nitrates, ACE Inhibitors, Ranolazine and Angina), By Application (Clinics, Hospitals and Other) Regional Forecast To 2031

Updated On: 22 April 2024

Angina Market Report Overview

• 

• Request a Free Sample to learn more about this report

The global angina market size was USD 11140 million in 2022 & the market is projected to touch USD 15996 million by 2031, exhibiting a CAGR of 4.1% during the forecast period. 

The COVID-19 pandemic has had a significant impact on the angina market. The market has been affected by a number of factors, including reduced demand for healthcare services, increased focus on COVID-19, and supply chain disruptions. As a result, the angina market is expected to decline in the short term. However, the market is expected to recover in the long term, as the pandemic subsides and demand for healthcare services returns to normal.

The angina market is a large and growing market with a number of advantages. The global prevalence of angina is estimated to be around 120 million people, and this number is expected to grow in the coming years. There is also a high demand for new and innovative treatments for angina, as well as a growing focus on preventive care. Governments in many countries are also providing financial support for the development of new treatments for angina. This makes the angina market an attractive market for pharmaceutical companies and other healthcare providers.

COVID-19 Impact: Imposed Restrictions in the Economy which led to a decline in demand for Angina Market

The COVID-19 pandemic has had a significant impact on the angina market. The market has been affected by a number of factors, including, Reduced demand for healthcare services. During the pandemic, many people have been reluctant to seek medical attention for non-urgent conditions, such as angina. This has led to a decrease in demand for angina drugs and treatments. Increased focus on COVID-19. Healthcare resources have been focused on treating COVID-19 patients, which has led to a decrease in the availability of resources for other conditions, such as angina. Supply chain disruptions. The COVID-19 pandemic has caused disruptions to the global supply chain, which has made it difficult for some companies to obtain the raw materials they need to manufacture angina drugs. As a result of these factors, the angina market is expected to decline in the short term. However, the market is expected to recover in the long term, as the pandemic subsides and demand for healthcare services returns to normal. In the United States, the number of hospital admissions for angina decreased by 28% in 2020 compared to 2019.In the United Kingdom, the number of prescriptions for angina drugs decreased by 10% in 2020 compared to 2019.The global market for angina drugs is expected to decline by 5% in 2021, but is expected to recover by 2022.Overall, the COVID-19 pandemic has had a significant impact on the angina market. However, the market is expected to recover in the long term, as the pandemic subsides and demand for healthcare services returns to normal.

LATEST TRENDS

"Higher Standards of Performance by Increase in Infrastructure Spending to Grow Market Potentially"

The rise of gene therapy. Gene therapy is a new and innovative treatment approach that has the potential to revolutionize the treatment of angina. Gene therapy involves the delivery of genetic material to cells in order to correct or modify a genetic defect. This approach has the potential to provide long-term relief from angina symptoms and reduce the risk of complications. The development of new drug delivery systems. New drug delivery systems are being developed that can improve the efficacy and safety of angina treatments. These systems include transdermal patches, oral capsules, and inhaled powders. These new delivery systems are making it easier for patients to take their medications and are improving the overall patient experience. The increasing use of telemedicine. Telemedicine is the use of telecommunications technology to deliver healthcare services remotely. This is becoming increasingly popular for the management of angina, as it allows patients to receive care from a specialist without having to travel to a hospital or clinic. The growing focus on preventive care. There is a growing focus on preventive care in the healthcare industry, and this is leading to an increased demand for treatments that can help to prevent angina or reduce the risk of complications. This includes lifestyle modifications, such as eating a healthy diet, exercising regularly, and quitting smoking. These are just some of the latest trends in the angina market. These trends are driving innovation in the market and making it easier for patients to manage their condition.

Angina Market Segmentation

• 

• Request a Free Sample to learn more about this report

• By Type

Based on type the angina market is classified as beta blockers, calcium antagonists, anticoagulants, antiplatelet, nitrates, ace inhibitors, ranolazine and angina.

• By Application

Based on application the angina market is classified as clinics, hospitals and other.

DRIVING FACTORS

"Increasing prevalence of angina"

The global prevalence of angina is estimated to be around 120 million people. This number is expected to grow in the coming years due to the aging population and the increasing prevalence of risk factors for angina, such as obesity, diabetes, and hypertension.

"Government support"

Governments in many countries are providing financial support for the development of new treatments for angina. This is helping to drive innovation in the market and make new treatments more affordable.

RESTRAINING FACTORS

"Several Challenges Associated with the Local Irritation to Restrain the Market"

The angina market is facing a number of restraining factors, including the high cost of treatment, adverse effects of medications, lack of awareness, and complications of angina. The high cost of treatment can be a barrier for some patients, and some medications used to treat angina can have adverse effects. Additionally, there is still a lack of awareness about angina in some parts of the world, and angina can lead to serious complications. These factors could limit the growth of the market in the coming years.

Angina Market REGIONAL INSIGHTS

• 

• Request a Free Sample to learn more about this report

"North America Region to Dominate the Market with Extensive Utilization and Multiplying Manufacturers"

The angina market is segmented by region into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is the largest market for angina drugs, followed by Europe and Asia-Pacific. The market in Asia-Pacific is expected to grow at the fastest pace in the coming years, due to the increasing prevalence of angina in the region, as well as the rising incomes and improving healthcare infrastructure. The market in Latin America and Middle East & Africa are also expected to grow at a moderate pace in the coming years.

KEY INDUSTRY PLAYERS

"Financial Players to Contribute Towards Expansion of Market"

The angina market is highly competitive, with a number of major players vying for market share. Some of the key industry players include Amgen, Eli Lilly and Company, Gilead Sciences, GlaxoSmithKline Plc, and Bayer AG. These companies are developing new and innovative treatments for angina, as well as investing in research and development. They are also expanding their geographic reach and developing partnerships with other healthcare companies.

List of Market Players Profiled

• Amgen (U.S)
• Taxus Cardium Pharmaceuticals (Canada)
• LegoChem Biosciences (South Korea)
• Lee’s Pharmaceutical (China)
• Milestone Pharmaceuticals (U.S)
• Juventas Therapeutics (U.S)
• ViroMed (U.S)
• Kuhnil Pharmaceutical (India)

REPORT COVERAGE

The SWOT analysis and information on future developments are covered in the study. The research report includes a study of a number of factors that promote market growth. This section also covers the range of numerous market categories and applications that could potentially affect the market in the future. The specifics are based on current trends and historical turning points. The state of the market's components and its potential growth areas over the following years. The paper discusses market segmentation information, including subjective and quantitative research, as well as the impact of financial and strategy opinions. Additionally, the research disseminates data on national and regional assessments that take into account the dominant forces of supply and demand that are influencing market growth. The competitive environment, including market shares of significant competitors, is detailed in the report along with fresh research methodology and player strategies for the anticipated time.